Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic significance, angiographic characteristics and impact of antithrombotic and anticoagulant therapy on outcomes in high versus low grade coronary artery ectasia: A long-term follow-up study.
Gunasekaran P, Stanojevic D, Drees T, Fritzlen J, Haghnegahdar M, McCullough M, Barua R, Mehta A, Hockstad E, Wiley M, Earnest M, Tadros P, Genton R, Gupta K. Gunasekaran P, et al. Among authors: earnest m. Catheter Cardiovasc Interv. 2019 Jun 1;93(7):1219-1227. doi: 10.1002/ccd.27929. Epub 2018 Nov 4. Catheter Cardiovasc Interv. 2019. PMID: 30393992
Impact of short term oral steroid use for intravenous contrast media hypersensitivity prophylaxis in diabetic patients undergoing nonemergent coronary angiography or interventions.
Amr BS, Lippmann M, Tobbia P, Isom N, Dalia T, Buechler T, Pierpoline M, Patel N, Hockstad E, Wiley M, Tadros P, Mehta A, Earnest M, Chen JG, Gupta K. Amr BS, et al. Among authors: earnest m. Catheter Cardiovasc Interv. 2020 Dec;96(7):1392-1398. doi: 10.1002/ccd.28618. Epub 2019 Nov 26. Catheter Cardiovasc Interv. 2020. PMID: 31769132
Use of non-warfarin oral anticoagulants instead of warfarin during left atrial appendage closure with the Watchman device.
Enomoto Y, Gadiyaram VK, Gianni C, Horton RP, Trivedi C, Mohanty S, Di Biase L, Al-Ahmad A, Burkhardt JD, Narula A, Janczyk G, Price MJ, Afzal MR, Atoui M, Earnest M, Swarup V, Doshi SK, van der Zee S, Fisher R, Lakkireddy DR, Gibson DN, Natale A, Reddy VY. Enomoto Y, et al. Among authors: earnest m. Heart Rhythm. 2017 Jan;14(1):19-24. doi: 10.1016/j.hrthm.2016.10.020. Epub 2016 Oct 19. Heart Rhythm. 2017. PMID: 27771552
Safety profiles of percutaneous left atrial appendage closure devices: An analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE) database from 2009 to 2016.
Jazayeri MA, Vuddanda V, Turagam MK, Parikh V, Lavu M, Atkins D, Earnest M, Di Biase L, Natale A, Wilber D, Reddy YM, Lakkireddy DR. Jazayeri MA, et al. Among authors: earnest m. J Cardiovasc Electrophysiol. 2018 Jan;29(1):5-13. doi: 10.1111/jce.13362. Epub 2017 Nov 1. J Cardiovasc Electrophysiol. 2018. PMID: 28988455
Endocardial (Watchman) vs epicardial (Lariat) left atrial appendage exclusion devices: Understanding the differences in the location and type of leaks and their clinical implications.
Pillarisetti J, Reddy YM, Gunda S, Swarup V, Lee R, Rasekh A, Horton R, Massumi A, Cheng J, Bartus K, Badhwar N, Han F, Atkins D, Bommana S, Earnest M, Nath J, Ferrell R, Bormann S, Dawn B, Di Biase L, Mansour M, Natale A, Lakkireddy D. Pillarisetti J, et al. Among authors: earnest m. Heart Rhythm. 2015 Jul;12(7):1501-7. doi: 10.1016/j.hrthm.2015.03.020. Epub 2015 Mar 14. Heart Rhythm. 2015. PMID: 25778430
Impact of Periprocedural Colchicine on Postprocedural Management in Patients Undergoing a Left Atrial Appendage Ligation Using LARIAT.
Gunda S, Reddy M, Nath J, Nagaraj H, Atoui M, Rasekh A, Ellis CR, Badhwar N, Lee RJ, DI Biase L, Mansour M, Ruskin JN, Natale A, Earnest M, Lakkireddy DR. Gunda S, et al. Among authors: earnest m. J Cardiovasc Electrophysiol. 2016 Jan;27(1):60-4. doi: 10.1111/jce.12869. Epub 2015 Dec 11. J Cardiovasc Electrophysiol. 2016. PMID: 26515657
98 results